The Blueprint project phase 1 study has revealed that three of the four PD-L1 IHC assays (Dako 22C3, Dako 28-8, and Ventana SP263) were closely aligned on tumor cell (TC) staining whereas the Ventana SP142 assay showed consistently fewer TCs stained in the same specimens [12]. Here, CD274 is linked to neoplasm.